Chiara Rusconi (Carlo Visco)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 39

Top Venues

Blood

Leukemia & lymphoma

Cancers

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, Massimo Mirandola, Karin E Smedby, Maria Chiara Tisi, Eva Giné, Alexandra Albertsson-Lindblad, Ana Marin-Niebla, Alice Di Rocco, Filipa Moita, Roberta Sciarra, Sandra Bašić-Kinda, Georg Hess, Anke Ohler, Christian W Eskelund, Alessandro Re, Isacco Ferrarini, Arne Kolstad, Riikka Räty, Francesca Maria Quaglia, Toby Andrew Eyre, Greta Scapinello, Piero Maria Stefani, Lucia Morello, Luca Nassi, Stefan Hohaus, Simone Ragaini, Vittorio Ruggero Zilioli, Riccardo Bruna, Federica Cocito, Annalisa Arcari, Mats Jerkeman, Chiara Rusconi
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study. Blood 144 (9) (2024)
Chiara Rusconi
More is not always better. Blood 144 (10) (2024)
Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, Massimo Mirandola, Karin E Smedby, Maria Chiara Tisi, Eva Giné, Alexandra Albertsson-Lindblad, Ana Marin-Niebla, Alice Di Rocco, Filipa Moita, Roberta Sciarra, Sandra Bašić-Kinda, Georg Hess, Anke Ohler, Christian W Eskelund, Alessandro Re, Isacco Ferrarini, Arne Kolstad, Riikka Räty, Francesca Maria Quaglia, Toby Andrew Eyre, Greta Scapinello, Piero Maria Stefani, Lucia Morello, Luca Nassi, Stefan Hohaus, Simone Ragaini, Vittorio Ruggero Zilioli, Riccardo Bruna, Federica Cocito, Annalisa Arcari, Mats Jerkeman, Chiara Rusconi
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study. Blood 144 (9) (2024)
Chiara Rusconi
More is not always better. Blood 144 (10) (2024)
Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, Massimo Mirandola, Karin E Smedby, Maria Chiara Tisi, Eva Giné, Alexandra Albertsson-Lindblad, Ana Marin-Niebla, Alice Di Rocco, Filipa Moita, Roberta Sciarra, Sandra Bašić-Kinda, Georg Hess, Anke Ohler, Christian W Eskelund, Alessandro Re, Isacco Ferrarini, Arne Kolstad, Riikka Räty, Francesca Maria Quaglia, Toby Andrew Eyre, Greta Scapinello, Piero Maria Stefani, Lucia Morello, Luca Nassi, Stefan Hohaus, Simone Ragaini, Vittorio Ruggero Zilioli, Riccardo Bruna, Federica Cocito, Annalisa Arcari, Mats Jerkeman, Chiara Rusconi
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study. Blood 144 (9) (2024)
Chiara Rusconi, Chiara Rusconi
Putting the brain into mantle cell lymphoma. Leukemia & lymphoma 64 (2) (2023)
Chiara Rusconi, Chiara Rusconi
Putting the brain into mantle cell lymphoma. Leukemia & lymphoma 64 (2) (2023)
Chiara Rusconi, Chiara Rusconi
Putting the brain into mantle cell lymphoma. Leukemia & lymphoma 64 (2) (2023)
Chiara Rusconi
Letting the mantle out of the bag. British journal of haematology (2023)
Chiara Rusconi, Chiara Rusconi
Putting the brain into mantle cell lymphoma. Leukemia & lymphoma 64 (2) (2023)
Zijun Y Xu-Monette, Yong Li, Thomas Snyder, Tiantian Yu, Tingxun Lu, Alexandar Tzankov, Chiara Rusconi, Govind Bhagat, Weidong Han, Karen Dybkær, April Chiu, Wayne Tam, Youli Zu, Eric D Hsi, Fredrick B Hagemeister, Yingjun Wang, Heounjeong Go, Maurilio Ponzoni, Andrés José Maria Ferreri, Michael Boe Møller, Benjamin M Parsons, Xiangshan Fan, J Henricus van Krieken, Miguel Angel Piris, Jane N Winter, Qingyan Au, Ilan R Kirsch, Ming-Zhi Zhang, John Shaughnessy, Bing Xu, Ken H H Young
Tumor-infiltrating normal B cells revealed by immunoglobulin repertoire clonotype analysis are highly prognostic and crucial for antitumor immune responses in DLBCL. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maria Chiara Tisi, Riccardo Moia, Caterina Patti, Andrea Evangelista, Simone Ferrero, Michele Spina, Monica Tani, Barbara Botto, Melania Celli, Benedetta Puccini, Emanuele Cencini, Alice Di Rocco, Claudio Chini, Chiara Ghiggi, Renato Zambello, Manuela Zanni, Roberta Sciarra, Riccardo Bruna, Martina Ferrante, Stefano Aldo Pileri, Francesca Maria Quaglia, Caterina Stelitano, Alessandro Re, Stefano Volpetti, Vittorio Ruggero Zilioli, Annalisa Arcari, Francesco Merli, Chiara Rusconi
Long term follow-up of Rituximab plus Bendamustine and Cytarabine (R-BAC) in elderly patients with newly diagnosed MCL. Blood advances (2023)
Elaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, Luciano Cascione, Valdemar Priebe, Zijun Y Xu-Monette, Xiaosheng Fang, Mingzhi Zhang, Chiara Rusconi, Alexandar Tzankov, Andrea Rinaldi, Jacopo Sgrignani, Emanuele Zucca, Davide Rossi, Andrea Cavalli, Giorgio Inghirami, David W Scott, Ken H Young, Francesco Bertoni
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. British journal of haematology (2023)
Chiara Rusconi, Chiara Rusconi
Putting the brain into mantle cell lymphoma. Leukemia & lymphoma (2023)
Chiara Rusconi, Chiara Rusconi
Putting the brain into mantle cell lymphoma. Leukemia & lymphoma 64 (2) (2023)
Ken H H Young, Yong Li, Zijun Y Xu-Monette, Jeremy S Abramson, Aliyah R Sohani, Govind Bhagat, Alexandar Tzankov, Chiara Rusconi, Shanxiang Zhang, Karen Dybkær, Zenggang Pan, Mina L Xu, Wayne Tam, Youli Zu, Eric D Hsi, Fredrick B Hagemeister, Heounjeong Go, J van Krieken, Jane N Winter, Maurilio Ponzoni, Andrés José Maria Ferreri, Michael Boe Møller, Miguel Angel Piris, Yingjun Wang, Mingzhi Zhang
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood advances (2022)
Maria Christina Cox, Luigi Marcheselli, Giorgia Scafetta, Chiara Rusconi, Stefan Hohaus, Ombretta Annibali, Gerardo Musuraca, Alberto Fabbri, Maria Cantonetti, Sabrina Pelliccia, Robel Papotti, Luigi Petrucci, Monica Tani, Roberta Battistini, Annalisa Arcari, Stefano Luminari, Gianluca Lopez, Eleonora Alma, Livio Pupo, Giuseppe Carli, Francesco Marchesi, Francesca Re, Stefania Scarpino, Emanuele S G D'amore, Luigi Maria Larocca, Antonella Bianchi, Giuseppina Pepe, Fiammetta Natalino, Paola Anticoli-Borza, Natalia Cenfra, Alessandro Andriani, Elisabetta Abruzzese, Cristiano Tesei, Lorenzo Leoncini, Silvia Asioli, Luigi Ruco, Arianna Di Napoli
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study. Leukemia 36 (11) (2022)
Denis Horgan, Jan Walewski, Igor Aurer, Chiara Rusconi, Eva Giné, Bogdan Fetica, Mats Jerkeman, Marta Kozaric, Maria Gomes da Silva, Martin Dreyling
Tackling Mantle Cell Lymphoma in Europe. Healthcare (Basel, Switzerland) 10 (9) (2022)
Pier Luigi Luigi Zinzani, Maurizio Martelli, Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Paolo Sportoletti, Alessandra Tedeschi, Marzia Varettoni, Chiara Rusconi
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement. Hematological oncology 40 (4) (2022)
Michele Merli, Sara Rattotti, Michele Spina, Francesca Re, Marina Motta, Francesco A Piazza, Lorella Orsucci, Andrés José Maria Ferreri, Omar Perbellini, Anna Dodero, Daniele Vallisa, Alessandro Pulsoni, Armando Santoro, Paolo Sacchi, Valentina Zuccaro, Emanuela Chimienti, Filomena Russo, Chiara Rusconi, Anna Linda Zignego, Luigi Marcheselli, Francesco Passamonti, Stefano Luminari, Marco Paulli, Raffaele Bruno, Luca Arcaini, null null
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Maurizio Martelli, Paolo Sportoletti, Chiara Rusconi, Pier Luigi Luigi Zinzani, Alessandra Tedeschi, Marzia Varettoni
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement. Hematological oncology 40 (3) (2022)
Sarah Bailly, Guillaume Cartron, Sridhar Chaganti, Raul Cordoba, Paolo Corradini, Johannes Düll, Isacco Ferrarini, Wendy Osborne, Andreas Rosenwald, Juan-Manuel Sancho, Herve Tilly, Eric Van Den Neste, Andreas Viardot, Chiara Rusconi
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper. Hematological oncology 40 (4) (2022)
Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, Valerio Zoli, Benedetta Puccini, Andrea Evangelista, Luca Arcaini, Leonardo Flenghi, Chiara Rusconi, Michael Mian, Alice Di Rocco, Claudia Peracchio, Manuel Gotti, Maria Chiara Tisi, Francesca Palombi, Samantha Pozzi, Daniela Gioia, Piera Viero, Maurizio Martelli
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study). Hematological oncology 40 (4) (2022)
Beatrice Casadei, Lisa Argnani, Alessandro Broccoli, Caterina Patti, Piero Maria Stefani, Antonio Cuneo, Gloria Margiotta Casaluci, Chiara Rusconi, Guido Gini, Fabrizio Pane, Francesco D'Alò, Debora Luzi, Maria Cantonetti, Samantha Pozzi, Gerardo Musuraca, Chiara Rosignoli, Annalisa Arcari, Sofya Kovalchuk, Monica Tani, Maria Chiara Tisi, Mario Petrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. Cancers 14 (3) (2022)
Riccardo Moia, Riccardo Dondolin, Maria Stefania De Propris, Donatella Talotta, Samir Mouhssine, Francesca Perutelli, Gianluigi Reda, Veronica Mattiello, Gian Matteo Rigolin, Marina Motta, Jacopo Olivieri, Renato Fanin, Omar Perbellini, Isacco Ferrarini, Francesca Romana Mauro, Ilaria Del Giudice, Luca Laurenti, Annamaria Tomasso, Massimo Gentile, Anna Maria Frustaci, Alessandra Tedeschi, Alessandro Gozzetti, Caterina Stelitano, Chiara Rusconi, Carol Moreno, Francesco Forconi, Roberto Marasca, Marta Coscia, Davide Rossi, Robin Foà, Gianluca Gaidano
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. Hematological oncology (2022)
Zijun Y Xu-Monette, Li Wei, Xiaosheng Fang, Qingyan Au, Harry Nunns, Máté Nagy, Alexandar Tzankov, Feng Zhu, Chiara Rusconi, Govind Bhagat, Karen Dybkær, April Chiu, Wayne Tam, Youli Zu, Eric D Hsi, Fredrick B Hagemeister, Xiaoping Sun, Xin Han, Heounjeong Go, Maurilio Ponzoni, Andrés J M Ferreri, Michael Boe Møller, Benjamin M Parsons, J Henricus van Krieken, Miguel A Piris, Jane N Winter, Yong Li, Bing Xu, Maher Albitar, Hua You, Ken H Young
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Giulia Bega, Jacopo Olivieri, Marcello Riva, Greta Scapinello, Rossella Paolini, Silvia Finotto, Roberto Sartori, Elisa Lucchini, Gianmarco Guandalini, Davide Facchinelli, Maria Chiara Tisi, Marco Basso, Laura Ballotta, Francesco A Piazza, Isacco Ferrarini, Chiara Rusconi
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma. Cancers 13 (23) (2021)
Miriam Marangon, Chiara Rusconi, Anna Maria Barbui, Annalisa Chiappella, Alberto Fabbri, Simone Ferrero, Sara Galimberti, Stefano Luminari, Gerardo Musuraca, Alessandro Re, Vittorio Ruggero Zilioli, Marco Ladetto
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy. Cancers 13 (2) (2021)
Chiara Rusconi, Riccardo Bazzoni, Francesca Maria Quaglia, Isacco Ferrarini, Costanza Fraenza, Mauro Krampera
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice. Cancers 12 (10) (2020)
Chiara Rusconi, Alice Di Rocco, Andrea Evangelista, Francesca Maria Quaglia, Maria Chiara Tisi, Lucia Morello, Vittorio Ruggero Zilioli, Chiara Rusconi, Stefan Hohaus, Roberta Sciarra, Alessandro Re, Cristina Tecchio, Annalisa Chiappella, Ana Marin-Niebla, Rory McCulloch, Guido Gini, Tommasina Perrone, Luca Nassi, Elsa Pennese, Piero Maria Stefani, Maria Christina Cox, Valentina Bozzoli, Alberto Fabbri, Valentina Polli, Simone Ferrero, Maria Isabel Alvarez De Celis, Antonello Sica, Luca Petrucci, Luca Arcaini, Simon A Rule, Mauro Krampera, Umberto Vitolo, Monica Balzarotti
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study. Leukemia 35 (3) (2020)
Isacco Ferrarini, Antonella Rigo, Chiara Rusconi, Mauro Krampera, Fabrizio Vinante
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment. Cancers 12 (12) (2020)
Rory McCulloch, Chiara Rusconi, Toby A Eyre, Rebecca Frewin, Neil Phillips, David L Tucker, Francesca M Quaglia, Annabel McMillan, Jonathan Lambert, Nicola Crosbie, Simon Rule
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy. British journal of haematology 189 (4) (2020)
Fulvio Massaro, Yana Stepanishyna, Martina Manni, Stefano Luminari, Sara Galimberti, Luigi Marcheselli, Chiara Rusconi, Cristina Tecchio, Caterina Stelitano, Francesco Angrilli, Mario Petrini, Francesco Merli, Massimo Federico
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma. British journal of haematology 192 (6) (2020)
Manman Deng, Zijun Y Xu-Monette, Lan V Pham, Xudong Wang, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Chiara Rusconi, Govind Bhagat, Karen Dybkær, April Chiu, Wayne Tam, Youli Zu, Eric D Hsi, Hua You, Jooryung Huh, Maurilio Ponzoni, Andrés J M Ferreri, Michael Boe Møller, Benjamin M Parsons, Fredrick Hagemeister, J Henricus van Krieken, Miguel A Piris, Jane N Winter, Yong Li, Bing Xu, Phillip Liu, Ken H Young
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. Molecular cancer research : MCR 19 (2) (2020)
Ling Li, Ruifang Sun, Yi Miao, Thai Tran, Lisa Adams, Nathan Roscoe, Bing Xu, Ganiraju C Manyam, Xiaohong Tan, Hongwei Zhang, Min Xiao, Alexandar Tzankov, Chiara Rusconi, Karen Dybkaer, Govind Bhagat, Wayne Tam, Eric D Hsi, J Han van Krieken, Hua You, Jooryung Huh, Maurilio Ponzoni, Andrés J M Ferreri, Michael Boe Møller, Miguel A Piris, Mingzhi Zhang, Jane N Winter, L Jeffrey Medeiros, George Z Rassidakis, Christine A Vaupel, Yong Li, Naveen Dakappagari, Zijun Y Xu-Monette, Ken H Young
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (6) (2019)
Stefano Luminari, Michele Merli, Sara Rattotti, Vittoria Tarantino, Luigi Marcheselli, Federica Cavallo, Marzia Varettoni, Benedetta Bianchi, Francesco Merli, Alessandra Tedeschi, Giuseppina Cabras, Francesca Re, Chiara Rusconi, Marcia Torresan Delamain, Emanuele Cencini, Michele Spina, Simone Ferrero, Angela Ferrari, Marina Deodato, Donato Mannina, Ombretta Annibali, Angela Rago, Lorella Orsucci, Irene Defrancesco, Marco Frigeni, Marina Cesaretti, Luca Arcaini
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study. Blood 134 (10) (2019)
Marco Frigeni, Caroline Besson, Chiara Rusconi, Helene Fontaine, Maria Goldaniga, Marcella Visentini, Alessandro Pulsoni, Harrys A Torres, Jan Peveling-Oberhag, Roberto Rossotti, Francesco Zaja, Luigi Rigacci, Michele Merli, Céline Dorival, Camille Alric, Francesco Piazza, Massimo Gentile, Angela Ferrari, Mario Pirisi, Luca Nassi, Sara Rattotti, Annamaria Frustaci, Michele Milella, Emanuele Cencini, Irene Defrancesco, Virginia Valeria Ferretti, Raffaele Bruno, Olivier Hermine, Luca Arcaini
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Leukemia 34 (5) (2019)
Chiara Rusconi, Maria C Tisi, Andrea Evangelista, Alice Di Rocco, Anna-Katharina Zoellner, Vittorio R Zilioli, Stefan Hohaus, Roberta Sciarra, Alessandro Re, Cristina Tecchio, Annalisa Chiappella, Lucia Morello, Guido Gini, Luca Nassi, Tommasina Perrone, Anna L Molinari, Alberto Fabbri, Maria C Cox, Erica Finolezzi, Simone Ferrero, Benedetta Puccini, Isabel Alvarez De Celis, Annalisa Arcari, Dario Marino, Michele Merli, Francesco Piazza, Massimo Gentile, Matteo Pelosini, Giacomo Loseto, Olivier Hermine, Martin Dreyling, Marco Ruggeri, Maurizio Martelli, Eva Hoster, Umberto Vitolo, null null
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. British journal of haematology 185 (5) (2018)
Luca Arcaini, Caroline Besson, Marco Frigeni, Hélène Fontaine, Maria Goldaniga, Milvia Casato, Marcella Visentini, Harrys A Torres, Veronique Loustaud-Ratti, Jan Peveling-Oberhag, Paolo Fabris, Roberto Rossotti, Francesco Zaja, Luigi Rigacci, Sara Rattotti, Raffaele Bruno, Michele Merli, Céline Dorival, Laurent Alric, Arnaud Jaccard, Stanislas Pol, Fabrice Carrat, Virginia Valeria Ferretti, Chiara Rusconi, Olivier Hermine
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood 128 (21) (2016)

Chiara Rusconi.css-eqlu8i{font-size:small;padding-left:4px;} (Carlo Visco)

Publication Activity (10 Years)

Top Topics

Top Venues

Chiara Rusconi (Carlo Visco)